Recombinant Yersinia pseudotuberculosis serotype O:3 Ribosome-recycling factor (frr)

How does the frr gene in Y. pseudotuberculosis serotype O:3 compare to other Yersinia species?

The frr gene in Y. pseudotuberculosis serotype O:3 shares significant sequence homology with other Yersinia species, particularly Y. pestis, with which it has approximately 99% sequence identity. This high conservation reflects the essential nature of the ribosome-recycling factor in bacterial translation.

Research has shown that while Y. pseudotuberculosis and Y. pestis share many conserved genes, their expression patterns can differ significantly. For instance, studies have found that the expression of many sRNAs conserved between Y. pseudotuberculosis and Y. pestis differs in both timing and dependence on regulatory factors like Hfq . This suggests that even highly conserved genes like frr might be regulated differently between species, potentially contributing to their distinct pathogenic profiles.

What are the key structural characteristics of recombinant Y. pseudotuberculosis serotype O:3 frr protein?

The recombinant Y. pseudotuberculosis serotype O:3 frr protein typically exhibits structural features common to bacterial ribosome-recycling factors. Based on structural analyses of frr proteins from related bacteria, the Y. pseudotuberculosis frr likely adopts a three-domain structure:

• N-terminal domain: Contains a nucleotide-binding motif important for interaction with the ribosome

• Central domain: Forms the core structural element with a characteristic fold

• C-terminal domain: Often involved in specific interactions with ribosomal components

The protein is relatively small (approximately 20 kDa) and typically contains conserved residues crucial for its interaction with ribosomes and with elongation factor G. Recombinant expression of the protein often includes affinity tags (such as His-tag or GST-tag) to facilitate purification, which may slightly alter its molecular weight compared to the native protein.

Similar to the approach used for other Y. pseudotuberculosis recombinant proteins, such as invasin, researchers can validate the structural integrity of recombinant frr through biochemical and biophysical methods . When expressing recombinant frr protein, researchers should consider the potential impact of affinity tags on protein structure and function.

What are the optimal expression systems for producing recombinant Y. pseudotuberculosis serotype O:3 frr protein?

The choice of expression system for recombinant Y. pseudotuberculosis serotype O:3 frr protein depends on research goals, required yield, and downstream applications. Several systems have proven effective for similar bacterial proteins:

E. coli-based expression systems:

• BL21(DE3): Often the first choice due to its deficiency in lon and ompT proteases

• Rosetta™ strains: Beneficial if the frr gene contains rare codons

• Arctic Express™: Useful if protein folding is an issue at higher temperatures

Expression vectors:

• pET series: For high-level expression under T7 promoter control

• pGEX series: For GST-fusion proteins that can improve solubility

• pMAL series: For MBP-fusion proteins that enhance solubility and folding

Based on studies of recombinant Y. pseudotuberculosis proteins, fusion protein approaches can be particularly effective. For example, researchers successfully expressed a GST-fused invasin C-terminal portion (GST-INVS) from Y. pseudotuberculosis that retained functional activity .

Optimization parameters:

A methodological approach involving testing multiple expression conditions is recommended to identify optimal parameters for obtaining functional recombinant frr protein.

How can researchers assess the functionality of recombinant Y. pseudotuberculosis frr protein in vitro?

Assessing the functionality of recombinant Y. pseudotuberculosis frr protein requires specific assays targeting its ribosome recycling activity:

In vitro translation-based assays:

• Polysome dissociation assay: Measure the ability of frr to dissociate polysomes in the presence of EF-G and GTP

• Ribosome release assay: Quantify the release of ribosomes from mRNA using radiolabeled or fluorescently labeled components

• Model post-termination complex (PoTC) disassembly: Assess frr's ability to disassemble artificially constructed PoTCs

Biochemical interaction studies:

• Surface Plasmon Resonance (SPR): Determine binding kinetics with ribosomes or ribosomal subunits

• Microscale Thermophoresis (MST): Analyze interactions with ribosomal components

• Pull-down assays: Identify binding partners using the recombinant frr as bait

Structural validation:

• Circular Dichroism (CD): Confirm proper secondary structure formation

• Thermal shift assays: Assess protein stability and proper folding

• Limited proteolysis: Evaluate the structural integrity of domains

Similar to the approach used for analyzing recombinant invasin from Y. pseudotuberculosis, researchers can employ western blotting and functional assays to confirm that the recombinant frr protein retains its native characteristics .

What role might the frr protein play in Y. pseudotuberculosis virulence and pathogenicity?

While the frr protein is primarily involved in protein synthesis, it may indirectly influence virulence and pathogenicity of Y. pseudotuberculosis through several mechanisms:

Stress response and adaptation:

• The frr protein could be critical for bacterial adaptation to host environments by ensuring efficient translation under stress conditions

• Similar to how IscR regulates virulence in Y. pseudotuberculosis, frr might influence virulence factor expression through its impact on translation efficiency

Growth and survival in host:

• Efficient ribosome recycling is essential for bacterial growth, particularly in nutrient-limited environments like those encountered during infection

• From studies of Y. pseudotuberculosis virulence, we know that proteins involved in fundamental cellular processes can significantly impact colonization ability

Potential interface with host defense:

• Translation machinery proteins like frr could potentially interact with host defense mechanisms

• Studies of Y. pseudotuberculosis have shown that even non-classical virulence factors can influence interactions with host immune cells

Research approaches to investigate this relationship could include:

• Construction of conditional frr mutants (as complete knockouts would likely be lethal)

• Evaluation of virulence gene expression in frr-limited conditions

• Assessment of bacterial fitness in infection models under frr modulation

• Proteomic analysis to identify changes in virulence factor production

The research approach could be modeled after studies like those on IscR in Y. pseudotuberculosis, which demonstrated significant reductions in colonization of Peyer's patches, mesenteric lymph nodes, spleens, and livers in mouse models when this regulatory protein was deleted .

What purification protocols are most effective for recombinant Y. pseudotuberculosis frr protein?

Effective purification of recombinant Y. pseudotuberculosis frr protein typically involves a multi-step approach:

Affinity chromatography (first step):

• Ni-NTA for His-tagged frr:

  • Lysis buffer: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 1 mM DTT

  • Wash buffer: Same with 20-30 mM imidazole

  • Elution buffer: Same with 250-300 mM imidazole

• Glutathione sepharose for GST-fusion:

  • Lysis buffer: PBS pH 7.4, 1 mM DTT

  • Elution buffer: 50 mM Tris-HCl pH 8.0, 10 mM reduced glutathione

Secondary purification:

• Ion exchange chromatography (IEX):

  • Depending on the theoretical pI of frr, choose:

  • Cation exchange (SP sepharose) for basic proteins

  • Anion exchange (Q sepharose) for acidic proteins

• Size exclusion chromatography (SEC):

  • Buffer: 20 mM HEPES pH 7.5, 150 mM NaCl, 1 mM DTT

  • Columns: Superdex 75 or 200, depending on protein size and oligomeric state

Tag removal considerations:

• For His-tags: TEV protease cleavage (if TEV site included)

• For GST-fusion: Thrombin or PreScission protease

• After cleavage, perform reverse affinity chromatography to remove the tag

Quality control assessments:

• SDS-PAGE to verify purity (>95%)

• Western blot to confirm identity

• Mass spectrometry for accurate molecular weight determination

• Dynamic light scattering for homogeneity analysis

Based on the approach used for purifying recombinant invasin from Y. pseudotuberculosis, researchers should carefully validate the functionality of purified frr protein using appropriate activity assays .

How can researchers validate the structure and function of recombinant frr protein?

Validating the structure and function of recombinant Y. pseudotuberculosis frr protein requires a comprehensive approach:

Structural validation:

Functional validation:

• Ribosome binding assays:

  • Surface Plasmon Resonance (SPR) to measure binding kinetics

  • Microscale Thermophoresis (MST) to determine affinity constants

  • Co-sedimentation assays with purified ribosomes

• GTPase stimulation assay:

  • Measure ability to stimulate EF-G-dependent GTP hydrolysis

  • Colorimetric phosphate release assays (e.g., malachite green)

• Polysome disassembly activity:

  • Monitor decrease in polysome fraction by sucrose gradient centrifugation

  • Quantify released 70S ribosomes and subunits

Using methods similar to those employed for analyzing recombinant Y. pseudotuberculosis proteins, researchers should employ multiple complementary techniques to thoroughly validate both structure and function .

What are the recommended approaches for studying frr-ribosome interactions in Y. pseudotuberculosis?

Studying frr-ribosome interactions in Y. pseudotuberculosis requires specialized approaches:

In vitro binding studies:

• Cryo-electron microscopy (Cryo-EM):

  • Visualize frr-ribosome complexes at near-atomic resolution

  • Identify binding sites and conformational changes

  • Sample preparation: Mix purified ribosomes with excess frr protein

• Biochemical crosslinking:

  • Use bifunctional crosslinkers to capture transient interactions

  • MS/MS analysis to identify crosslinked peptides

  • Zero-length crosslinkers to identify direct contacts

• Footprinting techniques:

  • Chemical (hydroxyl radical) footprinting to map protected regions

  • Selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE)

  • Dimethyl sulfate (DMS) probing of ribosomal RNA

Kinetic and thermodynamic analyses:

• Isothermal Titration Calorimetry (ITC):

  • Determine binding stoichiometry, affinity, and thermodynamic parameters

  • Typical experiment: 10-20 μM ribosome titrated with 100-200 μM frr

• Biolayer interferometry:

  • Real-time measurement of association and dissociation kinetics

  • Immobilize ribosomes on biosensors and measure frr binding

• Förster Resonance Energy Transfer (FRET):

  • Site-specific labeling of frr and ribosomal components

  • Monitor real-time binding and conformational changes

When interpreting results, researchers should consider the impact of experimental conditions on the interactions, particularly the roles of GTP, EF-G, and ion concentrations, which are known to affect translation machinery function in bacteria like Y. pseudotuberculosis.

How does temperature affect the expression and function of Y. pseudotuberculosis frr?

Temperature is a critical factor affecting gene expression in Y. pseudotuberculosis as it transitions between environmental (26°C) and host (37°C) temperatures. The impact on frr expression and function can be analyzed through several approaches:

Expression analysis across temperatures:

Note: These values represent typical patterns observed in translation machinery components in Yersinia species and should be experimentally verified for frr specifically.

Temperature-dependent functional changes:

• Structural stability:

  • Thermal shift assays can determine Tm values at different temperatures

  • CD spectroscopy to monitor temperature-induced conformational changes

  • Dynamic light scattering to detect aggregation propensity

• Interaction kinetics:

  • SPR or BLI measurements of ribosome binding at different temperatures

  • Analysis of association and dissociation rates (kon and koff)

  • Determination of temperature-dependent binding equilibrium (KD)

Based on studies of Y. pseudotuberculosis gene expression at different temperatures, we know that many genes show differential expression between 26°C and 37°C. The expression patterns of small RNAs that might regulate frr could also be temperature-dependent .

How can researchers interpret contradictory data regarding frr function in different experimental conditions?

Interpreting contradictory data regarding frr function in different experimental conditions requires a systematic approach:

Sources of experimental variability:

• Strain-specific differences:

  • Genomic variations between Y. pseudotuberculosis strains

  • Different serotypes may exhibit variable regulation patterns

  • Laboratory-adapted vs. clinical isolates may behave differently

• Experimental system variations:

  • In vitro vs. in vivo models

  • Recombinant vs. native protein studies

  • Different expression systems introducing artifacts

• Environmental condition effects:

  • Temperature-dependent changes (26°C vs. 37°C)

  • Growth phase variations (exponential vs. stationary)

  • Media composition altering metabolic state

Analytical framework for resolving contradictions:

When analyzing contradictory data, researchers should consider that Y. pseudotuberculosis adaptability to different environments may cause genuine biological variability in frr function. Studies of Y. pseudotuberculosis gene expression have shown significant differences depending on environmental conditions , suggesting that frr function may similarly vary with context.

What differential gene expression patterns might influence frr activity in Y. pseudotuberculosis during infection?

The frr protein's activity during infection may be influenced by various gene expression patterns in Y. pseudotuberculosis:

Key regulators affecting translation machinery:

• Global regulators:

  • IscR has been shown to regulate type III secretion and virulence in Y. pseudotuberculosis

  • Similar regulatory proteins might influence frr expression

  • Temperature-responsive regulators active at 37°C during infection

• Small RNAs:

  • Y. pseudotuberculosis expresses many sRNAs that differ from those in related species

  • These sRNAs could potentially regulate frr expression post-transcriptionally

  • The timing and conditions of sRNA expression may create infection stage-specific regulation

• Stress response systems:

  • Host-induced stresses trigger specific gene expression patterns

  • Translation machinery components often respond to these stress signals

  • Studies in Y. pseudotuberculosis have identified numerous stress-responsive genes

Methodological approaches to study infection-related expression:

• RNA-seq analysis comparing in vitro and in vivo conditions

• Ribosome profiling to assess translation efficiency during infection

• Reporter gene fusions to monitor frr promoter activity in animal models

• ChIP-seq to identify regulators binding to the frr promoter

• Proteomics to quantify frr protein levels during different infection stages

Understanding these regulatory patterns could help explain how Y. pseudotuberculosis adapts its translation machinery during the infection process, potentially revealing new targets for therapeutic intervention.

What are the current knowledge gaps in understanding Y. pseudotuberculosis frr and future research directions?

Despite advances in understanding Y. pseudotuberculosis biology, several knowledge gaps remain regarding the frr protein:

Current knowledge gaps:

• Structural details specific to Y. pseudotuberculosis frr versus other bacterial species

• Regulatory mechanisms controlling frr expression during infection

• Potential moonlighting functions beyond ribosome recycling

• Contribution to antibiotic resistance or tolerance mechanisms

• Serotype-specific variations in frr sequence and regulation

• Impact of host factors on frr function during infection

Future research directions:

• High-resolution structural studies of Y. pseudotuberculosis frr

• Systems biology approaches to place frr in the context of virulence networks

• Exploration of frr as a potential therapeutic target

• Investigation of post-translational modifications affecting frr activity

• Comparative studies across Yersinia species and serotypes

• Development of conditional frr mutants to assess essentiality in different contexts

Advances in these areas would significantly enhance our understanding of Y. pseudotuberculosis pathogenesis and potentially reveal new approaches for controlling Yersinia infections. The recent development of attenuated Y. pseudotuberculosis strains for vaccine delivery purposes demonstrates how fundamental research on this organism can lead to practical applications with significant public health impact.